Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BroncHI: Dexamethasone in Hospitalized Infants with Bronchiolitis
NCT05994183Phase 1Withdrawn
- Sponsor
- IDeA States Pediatric Clinical Trials Network
- Start
- Oct 2023
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dexamethasone in bronchiolitis, sponsored by IDeA States Pediatric Clinical Trials Network. Primary endpoint: Number of participants that receive 2 doses of dexamethasone per protocol at 30 days. Planned start Oct 2023; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT05994183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994183.